Archive · 31 Jan 2026
Google AI Tool Reads DNA to Spot Disease Risks
Google DeepMind has created a new AI tool called AlphaGenome.
This tool can read and analyze large parts of our DNA to find changes that might cause diseases.
It looks at how genes are turned on or off and how strongly they work in different cells.
Many common diseases, like heart disease and some cancers, are linked to these gene changes.
AlphaGenome can help scientists understand these changes better and might lead to new treatments.
The tool was trained using DNA data from humans and mice.
Experts say it's a big step forward, but more research is needed before it can replace lab experiments.
Google DeepMind launched AlphaGenome, an AI tool to analyze genetic mutations and gene regulation.
AlphaGenome can analyze up to one million DNA letters at a time and predict how mutations affect gene activity.
The tool was trained using publicly available human and mouse genetic data.
AlphaGenome can help identify genetic regions involved in diseases like cancer and support gene therapy development.
Experts see AlphaGenome as a major advancement but note further research is needed before it can replace lab experiments.
- Who
- Google DeepMind researchers and scientists
- What
- Launched AlphaGenome, an AI tool for analyzing genetic mutations and gene regulation
- When
- Recently (specific date not mentioned)
- Where
- Globally, using publicly available genetic data
- Why
- To improve understanding of the genome, accelerate disease research, and support gene therapy development
- Tool Name
- AlphaGenome
- Developer
- Google DeepMind
- Function
- Analyzes genetic mutations and gene regulation
- Data Capacity
- Up to one million DNA letters at a time
- Training Data
- Publicly available human and mouse genetic data
- Potential Applications
- Identifying disease-related genetic regions, developing gene therapies